benzoxazoles has been researched along with Colorectal Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, P; Boto, REF; Lima, E; Maia, A; Nunes, MJ; Reis, LV; Santos, AO; Serrano, JL; Silvestre, S | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Johnson, SM; O'Hagan, HM; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Ahn, J; Hwang, SG; Kim, JS; Nam, KY; Ryu, H; Song, JY | 1 |
| Akimoto, K; Inoue, K; Kubota, K; Shibuya, N; Tanaka, G | 1 |
| Chen, MB; Cui, JF; Li, C; Liu, CY; Liu, F; Lu, PH; Zhang, QD; Zou, J | 1 |
| Chung, HJ; Han, SY; Kim, JH; Kim, YC; Lee, HJ; Lee, J; Park, KR | 1 |
| Ahn, SH; Cha, HJ; Cho, SY; Ha, JD; Han, SY; Jung, H; Kang, SY; Kim, HR; Koh, JS; Lee, CO; Lee, J; Lee, MO; Ryu, JW | 1 |
7 other study(ies) available for benzoxazoles and Colorectal Neoplasms
| Article | Year |
|---|---|
An Insight into Symmetrical Cyanine Dyes as Promising Selective Antiproliferative Agents in Caco-2 Colorectal Cancer Cells.
Topics: Antineoplastic Agents; Benzoxazoles; Caco-2 Cells; Colorectal Neoplasms; Fluorescent Dyes; Humans; Quinolines | 2022 |
Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer.
Topics: Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Proliferation; Cell Survival; Chaperonin 10; Chaperonin 60; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Salicylanilides; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Proliferation; Chemoradiotherapy; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; HT29 Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Radiation Tolerance; Radiation-Sensitizing Agents; Signal Transduction; Transcription, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
Augmented pentose phosphate pathway plays critical roles in colorectal carcinomas.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzoxazoles; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Female; Glucose; Glutathione Disulfide; Glycolysis; Humans; Japan; Lactic Acid; Mice; Mice, Nude; Pentose Phosphate Pathway; Plant Extracts; Pyrimidines; Receptors, Peptide; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Treatment Outcome | 2015 |
The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cadherins; Carrier Proteins; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fluorouracil; HT29 Cells; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Microfilament Proteins; Multiprotein Complexes; Protein Kinase Inhibitors; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Effects of KRC-108 on the Aurora A activity and growth of colorectal cancer cells.
Topics: Aminopyridines; Apoptosis; Aurora Kinase A; Benzoxazoles; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Enzyme Activation; HT29 Cells; Humans; Lethal Dose 50 | 2015 |
Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo.
Topics: Administration, Oral; Aminopyridines; Animals; Antineoplastic Agents; Benzoxazoles; Cell Proliferation; Colorectal Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; fms-Like Tyrosine Kinase 3; HT29 Cells; Humans; Inhibitory Concentration 50; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |